|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS,
Matsuda T, Ng SS, Lau JY, Zheng S, Adler S, et al: An updated Asia
Pacific Consensus Recommendations on colorectal cancer screening.
Gut. 64:121–132. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu S, Zheng R, Zhang M, Zhang S, Sun X
and Chen W: Incidence and mortality of colorectal cancer in China,
2011. Chin J Cancer Res. 27:22–28. 2015.PubMed/NCBI
|
|
5
|
Handy B: The clinical utility of tumor
markers. Lab Med. 40:99–104. 2009. View Article : Google Scholar
|
|
6
|
Ng K, Meyerhardt JA, Chan AT, Sato K, Chan
JA, Niedzwiecki D, Saltz LB, Mayer RJ, Benson AB III, Schaefer PL,
et al: Aspirin and COX-2 inhibitor use in patients with stage III
colon cancer. J Natl Cancer Inst. 107:3452014.PubMed/NCBI
|
|
7
|
Siu AL; US Preventive Services Task Force
(USPSTF); Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW,
Ebell M, García FA, Gillman M, Herzstein J, et al: Screening for
colorectal cancer: US preventive services task force recommendation
statement. JAMA. 315:380–387. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang S, Xiang J, Li Z, Lu S, Hu J, Gao X,
Yu L, Wang L, Wang J, Wu Y, et al: A plasma microRNA panel for
early detection of colorectal cancer. Int J Cancer. 136:152–161.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Castells A: Colorectal cancer screening.
Gastroenterol Hepatol. 38(Suppl 1): S64–S70. 2015. View Article : Google Scholar
|
|
10
|
de Rosa M, Pace U, Rega D, Costabile V,
Duraturo F, Izzo P and Delrio P: Genetics, diagnosis and management
of colorectal cancer (Review). Oncol Rep. 34:1087–1096. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schreuders EH, Ruco A, Rabeneck L, Schoen
RE, Sung JJ, Young GP and Kuipers EJ: Colorectal cancer screening:
A global overview of existing programmes. Gut. 64:1637–1649. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bacac M, Fauti T, Sam J, Colombetti S,
Weinzierl T, Ouaret D, Bodmer W, Lehmann S, Hofer T, Hosse RJ, et
al: A novel carcinoembryonic antigen T-cell bispecific antibody
(CEA TCB) for the treatment of solid tumors. Clin Cancer Res.
22:3286–3297. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Wang X, He H, Liu Z, Hu JF and Li
W: Combination of circulating tumor cells with serum
carcinoembryonic antigen enhances clinical prediction of non-small
cell lung cancer. PLoS One. 10:e01262762015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang C, Zhan T, Liu Y, Li Q, Wu H, Ji D
and Li Y: Glycomic profiling of carcinoembryonic antigen isolated
from human tumor tissue. Clin Proteomics. 12:172015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu XY and Huang XE: Clinical application
of serum tumor abnormal protein (TAP) in colorectal cancer
patients. Asian Pac J Cancer Prev. 16:3425–3428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J and Huang XE: Clinical application
of serum tumor abnormal protein from patients with gastric cancer.
Asian Pac J Cancer Prev. 16:4041–4044. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar V, Al-Abbasi FA, Verma A, Mujeeb M
and Anwar F: Umbelliferone β-D-galactopyranoside exerts an
anti-inflammatory effect by attenuating COX-1 and COX-2. Toxicol
Res. 4:1072–1084. 2015. View Article : Google Scholar
|
|
19
|
Liu B, Qu L and Yan S: Cyclooxygenase-2
promotes tumor growth and suppresses tumor immunity. Cancer Cell
Int. 15:1062015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao Y, Wang J, Qin Y, Xuan Y, Jia Y, Hu
W, Yu W, Dai M, Li Z, Yi C, et al: Ku80 cooperates with CBP to
promote COX-2 expression and tumor growth. Oncotarget. 6:8046–8061.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang JY, Sun J, Huang MY, Wang YS, Hou MF,
Sun Y, He H, Krishna N, Chiu SJ, Lin S, et al: STIM1 overexpression
promotes colorectal cancer progression, cell motility and COX-2
expression. Oncogene. 34:4358–4367. 2015. View Article : Google Scholar : PubMed/NCBI
|
